Innovative Medicines Initiatives (IMI)

N. Seigneuret (Brussels, Belgium)

Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines

Number: 7

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Seigneuret (Brussels, Belgium). Innovative Medicines Initiatives (IMI). Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

The Innovative Medicines Initiative (IMI), a promising partnership to deliver new medicines to patients Source: Year: 2008
European Asthma Research and Innovation Partnership (EARIP) Source: Research Seminar 2013 - Translational animal models of asthma Year: 2013
National example: Italian Medicines' Agency Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines Year: 2014
The Innovative Medicines Initiative (IMI): a new opportunity for scientific collaboration between academia and industry at the European level Source: Eur Respir J 2008; 31: 924-926 Year: 2008
WHO Collaborating Research Centre for Children‘s Environmental Health: collaborative research strategies Source: Eur Respir J 2005; 26: Suppl. 49, 449s Year: 2005
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation Source: Eur Respir J 2016; 47: 1028-1033 Year: 2016
Translational Research Programmes – the physician- scientist Programme Source: Annual Congress 2009 - Lunchtime Programme "How can career development be achieved in European Respiratory Medicine" Year: 2009
How to assist bringing new drugs to patients: role of the European Medicines Agency Source: International Congress 2019 – Rare lung diseases Year: 2019
Health Research collaboration in Europe: an innovative initiative Source: Research Seminar 2013 - ERS Presidential Summit on Research gaps, patient needs and innovative solutions: a forward look on lung health research Year: 2013
The ERS Research Agency: the beginning Source: Eur Respir J 2016; 47: 1017-1023 Year: 2016
The future of asthma research and development: a roadmap from the European Asthma Research and Innovation Partnership (EARIP) Source: Eur Respir J, 49 (5) 1602295; 10.1183/13993003.02295-2016 Year: 2017
Towards the development of EU/EEA Standards for Tuberculosis Care (ESTC) Source: Eur Respir J 2011; 38: 493-495 Year: 2011
Medicines for Children - the UK experience Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening Year: 2006
World Health Organization Collaborating Centre for Research and Training in Management of MDR-TB – curricula and methods Source: Eur Respir J 2005; 26: Suppl. 49, 191s Year: 2005
The ERS European Forum for TB Innovation Source: Annual Congress 2013 –ERS/WHO joint lunchtime session "TB-Forum for innovation" Year: 2013
The International Collaboration to Improve Respiratory Health in Children (INCIRCLE) ERS Clinical Research Collaboration Source: Eur Respir J, 52 (6) 1801867; 10.1183/13993003.01867-2018 Year: 2018
Evaluation of the Integrated Tuberculosis Research Programme (PII TB) by SEPAR (Spanish Respiratory Society) Source: International Congress 2019 – Tuberculosis: a public health approach Year: 2019
Impact of A Digital Health Intervention On Asthma Healthcare Utilization Source: International Congress 2017 – Asthma: mechanisms and treatment Year: 2017
Economic evaluation of the British Lung Foundation Active Steps service Source: Virtual Congress 2021 – New approaches to pulmonary rehabilitation and chronic care Year: 2021